@article{article, title  = {{Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis}},

 publisher = {{American Medical Association (AMA)}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/200864 }},

 year = {{2023}},

 month = {{5}},

 author = {{Kalincik T and Sharmin S and Roos I and Freedman MS and Atkins H and Burman J and Massey J and Sutton I and Withers B and Macdonell R and Grigg A et al}},

 doi = {{10.1001/jamaneurol.2023.1184}},

 volume = {{80}},

 journal = {{JAMA Neurology}},

 issue = {{7}},

 pages = {{702-713}},

 note = {{Accessed on 2024/12/28}}}